IDIGH

A sincere thank you to Dr. Inés Colmegna for an engaging seminar on April 22 as part of our IDIGH Research Townhall Series.

Her presentation, “Patient-Derived Stem/Progenitor Cells: From Clinical Challenge to Clinical Trial,” led to thoughtful discussions and highlighted important work in the field.

Thank you as well to everyone who attended and participated in another successful townhall session.

Join us tomorrow for the 10th Annual IDIGH Research Day!
A full day of inspiring talks, research, and innovation.
📅 April 28 | ⏰ 8:00–18:00

We are excited to invite you to this year’s IDIGH Career Day, Shaping Your Future: Second Edition 🎉 an afternoon dedicated to career exploration, professional growth, and meaningful connection.
This event is designed with you in mind. Whether you are early in your training or actively planning your next step, the program offers practical insight, honest conversations, and tools to help you move forward with clarity and confidence.
What to expect:
🎓 Student Success Panel
Hear candid reflections and lessons learned from fellow trainees.
💼 Professional Panel
Engage with speakers from diverse sectors discussing career paths, transitions, and decision making.
🧠 Wellness Session
Explore strategies for resilience, balance, and sustaining well being during training.
🛠 Interactive Workshop
Develop concrete next steps to support your professional development.
🥂 Cocktail Hour
Connect with speakers, mentors, and peers in a relaxed networking setting.
This is a valuable opportunity to gain perspective beyond your immediate research environment, ask thoughtful questions, and strengthen your professional network within the IDIGH community.
📅 Date: March 18, 2026 | 🕐 Time: 1:00 PM – 6:00 PM
🔗 Register here: https://www.eventbrite.ca/e/1983210014540?aff=oddtdtcreator
🌐 Official Event Website: https://ri.idigh.ca/careerday2026/
Space is limited, so we encourage you to reserve your spot early.

A wonderful Valentine’s Day & Lunar New Year celebration with our IDIGH community! ❤️🧧

It was such a joy to see so many IDIGH members come together for an afternoon filled with great food, creative card making, laughter, and community spirit.

A huge thank you to the IDIGH Community Research Engagement Committee (CREC), our amazing main organizers Kaitlin and Maya, the entire CREC team, everyone who helped behind the scenes, and all those who attended and made the event so special.

We are so grateful for this wonderful community.

🧬 Les résultats encourageants du tout premier essai clinique d’une immunothérapie contre le VIH sont publiés dans le journal Nature Medicine.

Ceux-ci apportent un nouvel espoir : la possibilité de contrôler le VIH en renforçant le système immunitaire — sans avoir recours à un traitement antirétroviral quotidien, souvent difficile à suivre. Mené au Service des maladies virales chroniques du CUSM, ainsi que dans 10 autres sites aux États-Unis et en Australie, cet essai de phase 1 a été commandité par AbbVie.

🔬 Cette avancée s’appuie sur des années de recherche et d’engagement du Dr Jean-Pierre Routy, investigateur principal de l’étude et scientifique principal au sein du Programme en maladies infectieuses et immunité en santé mondiale de L’Institut, ainsi que d’autres chercheurs montréalais, qui ont exploré, dans les cellules de patients vivant avec le VIH, comment cibler et bloquer la voie PD-1 — un « frein » qui empêche les cellules T de combattre efficacement le virus.

🔗 Pour en savoir plus : https://rimuhc.ca/fr/-/l-immunotherapie-un-nouvel-espoir-pour-controler-le-vih-sans-traitement-quotidien

//

🧬 Encouraging results from the first clinical trial of an HIV immunotherapy have just been published in Nature Medicine.

The study offers new hope: the potential to control HIV by strengthening the immune system — without the need for daily antiretroviral therapy, which can be difficult to maintain. Conducted at the MUHC Chronic Viral Illness Service, along with 10 other sites in the United States and Australia, this phase 1 trial was sponsored by AbbVie.

🔬 The findings build on years of research and dedication by Dr. Jean-Pierre Routy, principal investigator of the study and Senior Scientist in the IDIGH Program at The Institute, together with other Montréal researchers who have explored how to target and block the PD-1 pathway — a key immune “brake” that prevents T cells from effectively fighting the virus.

🔗 Learn more https://rimuhc.ca/en/-/immunotherapy-approach-offers-hope-for-long-term-hiv-control-without-daily-medication

Centre universitaire de santé McGill - McGill University Health Centre McGill Faculty of Medicine and Health Sciences McGill University Fondation CUSM - MUHC Foundation Canadian Institutes of Health Research